FDA issues warnings to duodenoscope makers linked to infection outbreaksBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h4544 (Published 20 August 2015) Cite this as: BMJ 2015;351:h4544
- Michael McCarthy
The US Food and Drug Administration has sent warning letters1 to three makers of duodenoscopes whose devices have been linked to outbreaks of multidrug resistant strains of carbapenem resistant enterobacteriaceae. The three firms are Olympus Medical Systems, Fujifilm, and the Pentax division of Hoya.
The letters fault two of the manufacturers for failing to alert the FDA promptly after they learnt that patients had developed infections after undergoing endoscopic procedures with their devices, in one case waiting three years to file the required report. Under federal rules …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial